George Gauthier's most recent trade in IGM Biosciences Inc was a trade of 936 Common Stock done at an average price of $9.4 . Disclosure was reported to the exchange on July 3, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| IGM Biosciences Inc | George Gauthier | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 9.42 per share. | 03 Jul 2023 | 936 | 40,017 (0%) | 0% | 9.4 | 8,818 | Common Stock |
| IGM Biosciences Inc | George Gauthier | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 12.30 per share. | 23 May 2023 | 1,244 | 40,968 (0%) | 0% | 12.3 | 15,302 | Common Stock |
| IGM Biosciences Inc | George Gauthier | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 23 May 2023 | 15 | 40,953 (0%) | 0% | 13 | 195 | Common Stock |
| IGM Biosciences Inc | George Gauthier | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2023 | 8,334 | 42,212 (0%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | George Gauthier | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 32,500 | 32,500 | - | - | Stock Option (right to buy) | |
| IGM Biosciences Inc | George Gauthier | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 16,250 | 34,813 (0%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | George Gauthier | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 12.60 per share. | 04 Apr 2023 | 935 | 33,878 (0%) | 0% | 12.6 | 11,781 | Common Stock |
| IGM Biosciences Inc | George Gauthier | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 18.73 per share. | 14 Mar 2023 | 1,061 | 18,563 (0%) | 0% | 18.7 | 19,875 | Common Stock |
| IGM Biosciences Inc | George Gauthier | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 18.77 per share. | 16 Dec 2022 | 2,800 | 21,178 (0%) | 0% | 18.8 | 52,569 | Common Stock |
| IGM Biosciences Inc | George Gauthier | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 19.36 per share. | 16 Dec 2022 | 1,554 | 19,624 (0%) | 0% | 19.4 | 30,085 | Common Stock |
| IGM Biosciences Inc | George Gauthier | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 21.38 per share. | 23 Nov 2022 | 861 | 24,375 (0%) | 0% | 21.4 | 18,405 | Common Stock |
| IGM Biosciences Inc | George Gauthier | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 21.99 per share. | 23 Nov 2022 | 397 | 23,978 (0%) | 0% | 22.0 | 8,731 | Common Stock |
| IGM Biosciences Inc | George Gauthier | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 17.10 per share. | 24 May 2022 | 1,340 | 25,236 (0%) | 0% | 17.1 | 22,917 | Common Stock |
| IGM Biosciences Inc | George Gauthier | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 12.38 per share. | 13 May 2022 | 413 | 26,576 (0%) | 0% | 12.4 | 5,113 | Common Stock |
| IGM Biosciences Inc | George Gauthier | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 8,096 | 26,163 (0%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | George Gauthier | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2022 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| IGM Biosciences Inc | George Gauthier | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2022 | 7,500 | 18,067 (0%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | George Gauthier | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 50.99 per share. | 15 Nov 2021 | 367 | 567 (0%) | 0% | 51.0 | 18,713 | Common Stock |